{"product_id":"the-new-hepatitis-c","title":"The New Hepatitis C","description":"\u003cp\u003eFueled in part by the opioid epidemic, the number of reported hepatitis C virus infections tripled in the United States between 2010 and 2015. As new infections continue to mount, new therapies have produced seismic changes in how HCV is treated clinically, leaving a gap between the most current clinical guidance and the ongoing demands of patient care. The New Hepatitis C is a current and essential review of HCV's epidemiology, diagnosis, and clinical approaches -- a clinician's guidebook for navigating everything from screening to treatment. Acute and chronic HCV are addressed, as are important new treatment options for HCV, management of side effects, and a convenient summary of clinical trials on the treatment of chronic hepatitis C. Updated to detail the standards of care that will define the next decade of HCV management, this evidence-based volume is an essential clinical reference for to any practitioner in gastroenterology, hepatology, infectious disease, transplant, or internal medicine.\u003c\/p\u003e","brand":"Nancy Reau","offers":[{"title":"Default Title","offer_id":43643457241149,"sku":"9780190238285","price":160.95,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0597\/7689\/2989\/files\/9780190238285_3a47eee9-2b96-4f1f-8d7c-d907055ae906.jpg?v=1789685328","url":"https:\/\/www.palmleaf.com.au\/products\/the-new-hepatitis-c","provider":"Palmleaf","version":"1.0","type":"link"}